FDA
- Status: approved
intranasal saline solution plus glycerol (intranasal saline solution plus glycerol) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Unidad de Investigacion en Enfermedades Cronico-Degenerativas is the originator. The local marketing authorisation holder may differ — check the official source linked above.